415 related articles for article (PubMed ID: 38673047)
1. Clinical Application of Different Liquid Biopsy Components in Hepatocellular Carcinoma.
Xu J; Zhao Y; Chen Z; Wei L
J Pers Med; 2024 Apr; 14(4):. PubMed ID: 38673047
[TBL] [Abstract][Full Text] [Related]
2. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
Moldogazieva NT; Zavadskiy SP; Terentiev AA
Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
[TBL] [Abstract][Full Text] [Related]
3. Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma.
Yang JC; Hu JJ; Li YX; Luo W; Liu JZ; Ye DW
Front Oncol; 2022; 12():781820. PubMed ID: 35211399
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Ye Q; Ling S; Zheng S; Xu X
Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
[TBL] [Abstract][Full Text] [Related]
5. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Li J; Han X; Yu X; Xu Z; Yang G; Liu B; Xiu P
J Exp Clin Cancer Res; 2018 Sep; 37(1):213. PubMed ID: 30176913
[TBL] [Abstract][Full Text] [Related]
6. Liquid Biopsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring.
Shaik MR; Sagar PR; Shaik NA; Randhawa N
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445822
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma.
Temraz S; Nasr R; Mukherji D; Kreidieh F; Shamseddine A
Expert Rev Mol Diagn; 2022 May; 22(5):507-518. PubMed ID: 35758097
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.
Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R
Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301
[TBL] [Abstract][Full Text] [Related]
9. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
[TBL] [Abstract][Full Text] [Related]
11. Utility of Liquid Biopsy Analysis in Detection of Hepatocellular Carcinoma, Determination of Prognosis, and Disease Monitoring: A Systematic Review.
Chen VL; Xu D; Wicha MS; Lok AS; Parikh ND
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2879-2902.e9. PubMed ID: 32289533
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma.
Hu S; Liu Y; Yang Q; Chen L; Chai H; Xiao M; Qi C; Qiu W
Invest New Drugs; 2023 Jun; 41(3):532-538. PubMed ID: 37099161
[TBL] [Abstract][Full Text] [Related]
13. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.
Ahn JC; Teng PC; Chen PJ; Posadas E; Tseng HR; Lu SC; Yang JD
Hepatology; 2021 Jan; 73(1):422-436. PubMed ID: 32017145
[TBL] [Abstract][Full Text] [Related]
14. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
[TBL] [Abstract][Full Text] [Related]
15. The Application of Liquid Biopsy Techniques in High-Risk Population for Hepatocellular Carcinoma.
Ding J; Zhao W
Cancer Manag Res; 2022; 14():2735-2748. PubMed ID: 36133739
[TBL] [Abstract][Full Text] [Related]
16. Liquid biopsy for early detection of hepatocellular carcinoma.
Manea I; Iacob R; Iacob S; Cerban R; Dima S; Oniscu G; Popescu I; Gheorghe L
Front Med (Lausanne); 2023; 10():1218705. PubMed ID: 37809326
[TBL] [Abstract][Full Text] [Related]
17. Clinical applications of circulating tumor cells in hepatocellular carcinoma.
Hua Y; Dong J; Hong J; Wang B; Yan Y; Li Z
Front Oncol; 2022; 12():968591. PubMed ID: 36091119
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Performance of Circulating Tumor Cells for Predicting of Hepatocellular Carcinoma in Hepatitis C Virus-High Risk Patients: Role of Liquid Biopsy.
El-Mezayen HA; El -Kassas M; El-Taweel FM; Metwally FM; Ghonaim NA; Zahran RF
Asian Pac J Cancer Prev; 2022 Jul; 23(7):2541-2549. PubMed ID: 35901363
[TBL] [Abstract][Full Text] [Related]
19. The use of cell free DNA in the diagnosis of HCC.
Banini BA; Sanyal AJ
Hepatoma Res; 2019; 5():. PubMed ID: 31673629
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]